Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium protein and nucleic acid synthesis machinery encompasses all key protein and RNA complexes responsible for transcription and translation within Plasmodium parasites, including RNA polymerases, ribosomes (40S and 60S subunits), and various translation factors and enzymes such as aminoacyl-tRNA synthetases. These molecular systems enable the parasite to read genetic information, generate messenger RNA, and assemble proteins essential for parasite growth, reproduction, and pathogenicity. They differ structurally and functionally from human homologs, offering opportunities for targeted drug development. Investigational and clinically used antimalarial compounds aim to disrupt these molecular machineries, but selectivity and resistance remain significant therapeutic challenges. This entry is too broad for a canonical molecular target form, as it refers to an entire functional class rather than a specific molecule or defined protein complex. For drug-target annotation, it is preferable to specify individual molecular targets (e.g., "Plasmodium ribosomal protein S9" or "Plasmodium RNA polymerase I") rather than the overarching term.
Inhibition of protein synthesis (ribosome-binding or translation-blocking drugs); Inhibition of nucleic acid synthesis (blocking RNA polymerase or transcription machinery); Direct interaction/blockade of essential proteins in glideosome and translation complexes
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium protein and nucleic acid synthesis machinery.